Head-to-Head Study: EscharEx Bests Santyl for Treating VLUs
MediWound Ltd’s EscharEx bested market leader collagenase Santyl ointment in wound debridement, promotion of granulation tissue, and time to wound closure in patients with chronic venous leg ulcers (VLU). EscharEx is a bioactive, multimodal debridement therapy for the treatment of chronic and other hard-to-heal wounds that is currently in the advanced stages of clinical development. […]
New Thinking About Non-melanoma Skin Cancer Treatment
Checkpoint inhibitors have changed the way that many types of cancer are treated, and these powerful immunotherapy drugs may also have a role in basal cell carcinoma and squamous cell carcinoma, according to Andrew Weinstein, MD, a dermatologist in Boynton Beach, FL.
Is a Pharmacologic Treatment for Neurofibromatosis Type 1 Skin Tumors on the Horizon?
Current treatment for neurofibromatosis type 1 skin tumors involves monitoring the tumors and removing them surgically if necessary, but this isn’t ideal as neurofibromas can grow back and continue originating in other parts of the body, plus surgery leaves scars. Now, scientists have identified a key player in the protein signature: the GPR68 receptor. When it is activated […]